Benjamin Paluch

Stock Analyst at Roth MKM

(1.27)

# 3,704

Out of 5,120 analysts

3

Total ratings

33.33%

Success rate

0.8%

Average return

Main Sectors:

Top Industries:

Stocks Rated by Benjamin Paluch

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	CGON CG Oncology	Initiates: Buy	$65	$54.34	+19.62%	1	Aug 27, 2024
	REPL Replimune Group	Initiates: Buy	$17	$6.98	+143.73%	1	Aug 27, 2024
	GNLX Genelux	Initiates: Buy	$10	$2.73	+266.30%	1	Aug 27, 2024

CG Oncology

Aug 27, 2024

Initiates: Buy

Price Target: $65

Current: $54.34

Upside: +19.62%

Replimune Group

Aug 27, 2024

Initiates: Buy

Price Target: $17

Current: $6.98

Upside: +143.73%

Genelux

Aug 27, 2024

Initiates: Buy

Price Target: $10

Current: $2.73

Upside: +266.30%